RDY EBITDA Growth
Dr. Reddy's Laboratories Ltd Common Stock · EBITDA Growth
RDY EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-37.67%period ending
RDY TTM EBITDA YoY % (-27.49% → -37.67%)
Year-over-year change
High-resolution chart · PNG
RDY ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -37.6741% | |
| -18.6649% | |
| 4.0761% | |
| 11.4187% | |
| 43.1378% | |
| 40.0496% | |
| 76.9511% | |
| 81.8134% | |
| 42.9776% | |
| 51.8302% | |
| 14.8521% | |
| 30.4352% | |
| 29.1758% | |
| 51.391% | |
| 66.2791% | |
| 47.8108% | |
| 45.772% | |
| 9.1612% | |
| -28.392% | |
| -12.7353% | |
| -30.8684% | |
| -25.8486% | |
| 7.6629% | |
| -29.1467% | |
| -4.2879% | |
| 6.4002% | |
| 9.8542% | |
| 34.2296% | |
| 36.6805% | |
| 45.225% | |
| 28.792% | |
| 20.8479% | |
| 14.2353% | |
| -6.3863% | |
| -9.559% | |
| -11.9854% | |
| -27.6518% | |
| -37.1466% | |
| -32.6316% | |
| -27.3079% | |
| -5.4216% | |
| 16.8615% | |
| 18.4718% | |
| 13.7021% | |
| 3.4479% | |
| 6.0871% | |
| 6.0129% | |
| 21.9705% | |
| 32.5109% | |
| 26.7519% | |
| 43.2255% | |
| 11.3609% | |
| 9.0649% | |
| 11.2213% | |
| 38.6682% | |
| 37.9188% | |
| 35.622% | |
| 189.5393% | |
| 198.8362% | |
| 157.5661% | |
| 409.949% | |
| 34.2888% | |
| 56.406% | |
| 295.8674% | |
| -140.037% | |
| -49.1361% | |
| -58.1511% | |
| -81.8145% | |
| 9.8695% | |
| -23.7405% | |
| -37.4818% | |
| -35.8095% | |
| 8.8428% | |
| 52.6759% | |
| 225.5191% | |
| 488.4478% | |
| 517.3239% | |
| 547.2668% | |
| 338.6019% | |
| 221.0079% | |
| 4.6869% | |
| -47.3145% | |
| -63.9571% | |
| -78.7636% | |
| -60.595% | |
| -42.2984% | |
| -30.2146% | |
| -18.4811% | |
| -13.4186% | |
| -25.9197% | |
| -41.1416% | |
| -27.489% |